Catalyst Wire Dossier Catalyst Wire Dossier

ASC40 (Denifanstat)

Denifanstat · Ascletis Pharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC40 (Denifanstat), covering 2025-06-19 to 2025-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris [Phase 3]

See pricing